doi: 10.1113/jphysiol.2009.179325 59 LuHHuangDSaederupNCharoIFRansohoffRMZhouL
EMA401 showed analgesic efficacy and safety in two randomized, double-blind, phase 2 studies of postherpetic neuralgia and painful DN
Current prescribing information focuses instead on recognized risks such as gastrointestinal adverse reactions, dehydration-related kidney injury, gallbladder disease, pancreatitis, and hypoglycemia in susceptible patients
What if I want a different target concentration
At ouroffice in Brooklyn, we regularly help patients manage these effects safely and comfortably
Dispensed by Licensed Pharmacy Prescription Required (If Applicable) WHO-GMP Certified Manufacturers Verified by Registered Pharmacist Cyanocobalamin IP eq